Navigation Links
Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting

GENEVA, Switzerland, May 2, 2007 – Merck Serono S.A. (virt-x: SEO) announced today that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson’s disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA. These data are from a 6-month (24 weeks), randomized, double blind, placebo-controlled, international trial.

"These data are promising for patients with Parkinson’s disease," said Fabrizio Stocchi, Professor of Neurology and Honorary Consultant at the IRCCS San Raffaele Rome, University La Sapienza, and principal investigator of the study. "The data not only show the benefit of safinamide on motor symptoms and activities of daily living, but also indicate an effect on cognitive performance, which may represent a major advantage for the patient."

The data demonstrated that the addition of safinamide to a stable dose of a single dopamine agonist in patients with early stage Parkinson’s disease resulted in a statistically significant improvement in motor symptoms, as measured by the Unified Parkinson’s Disease Rating Scale1 (UPDRS) Part III Motor Score (primary endpoint). After 24 weeks of treatment with safinamide at the dose of 50 to 100 mg once daily, the UPDRS Part III Motor Score was significantly improved over the effect of dopamine agonist monotherapy (difference between end of study and baseline of minus 6.0 ± 7.2 in the safinamide-treated group versus minus 3.6 ± 7.1 in the placebo group; p=0.0419; 95% CI=[-3.7;-0.1]).

In addition, treatment with safinamide at the dose of 50 to 100 mg once daily over a 24-week period resulted in a significant improvement of UPDRS Part II Activities of Daily Living Score, compared with dopamine agonist monotherapy (difference between end of stu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/24/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based ... results for the second quarter ended June 30, 2014. ... of $6.5 million in the second quarter of 2014, an ... , Total revenues of $13.3 million for the six months ... same period in 2013 , Total revenues generated from ...
(Date:7/24/2014)... RALEIGH-DURHAM, N.C. , July 24, 2014 /PRNewswire/ ... company has signed an Agreement with Kineticos, a ... sciences consulting company. Kineticos will support LSI Medience ... in sepsis management, to demonstrate utility in clinical ... has shown potential utility in diagnosis of sepsis, ...
(Date:7/24/2014)...  The American Association for Homecare (AAHomecare) yesterday ... help address audit issues in the HME industry ... the information technology lead in shaping its HME ... billing and business management solutions for nearly 3,000 ... support this important initiative on behalf of all ...
Breaking Medicine Technology:IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2
... China , July 22 /PRNewswire-Asia-FirstCall/ -- ... developing and producing botanical extracts and other raw ... receipt of its,European order for approximately 80 metric ... pharmaceutical company. This order is valued at,approximately ...
... A total joint replacement registry based on carefully designed and ... according to a paper published online in Clinical Orthopaedics and Related ... , , ... Permanente,s Total Joint Replacement Registry -- the nation,s largest such registry -- ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order 2Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order 3Kaiser Permanente Demonstrates Success of Large-Scale Total Joint Replacement Registry 2Kaiser Permanente Demonstrates Success of Large-Scale Total Joint Replacement Registry 3Kaiser Permanente Demonstrates Success of Large-Scale Total Joint Replacement Registry 4
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 The ... new online training course designed to help users generate ... public generating a buzz of excitement throughout the internet ... caught the attention of HonestyFirstReviews.com’s Tiffany Hendricks prompting a ... anyone who’s been involved in internet marketing will tell ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Ticket Down ... Roma Tickets in Denver at the Sports Authority Field on ... (or World Football Challenge) has brought some of the best club ... With the World Cup still being raved about weeks after its ... chance to see some of the biggest stars in the world ...
(Date:7/24/2014)... The report, “Content Delivery Networks (CDN) Market”, ... sub-segments with an in-depth analysis and forecasting of ... for this market with insights on trends, opportunities, ... and 36 figures spread through 157 pages and ... at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . , Early buyers ...
(Date:7/24/2014)... York, New York (PRWEB) July 24, 2014 ... GranuFlo lawsuits ( http://www.injurybeacon.com/granuflo-dialysis/lawsuit/ ) in the ... a qualified protective order for plaintiff medical information ... Accountability Act. According to the July 16th Order, ... granted attorneys for Fresenius Medical Care the ...
(Date:7/24/2014)... In a July 9th article in the Money ... Lotus Blossom Consulting LLC , was quoted in a Family ... Cut the High Cost of Infertility . Her advice began ... maximize your chance of success from the first attempt.” The ... “I am always happy to talk with the media ...
Breaking Medicine News(10 mins):Health News:Traffic And Leads Training Academy - Review Examining Jeff Johnson’s New IM Course Released 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 2Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 3
... ... A valuing parent/child relationship is required, not just discipline. , ... (PRWEB) May 20, 2010 -- There’s a dangerous parenting trend ... discipline (to spank or not to spank, etc.) with little to no attention on a ...
... The Swanson ... with unique benefits. , ... ND (Vocus) May 19, 2010 -- Friendly bacteria may seem like an oxymoron—we have been ... everyone needs bacteria to survive. Bacteria are responsible for the digestion of food, for ...
... Hands-On Care ... Manual Physical Therapy have been producing pain relief in otherwise unresolved chronic pain cases. ... (PRWEB) May 20, 2010 -- ... Myofascial Pain examine and treat chronic pain sufferers from all over the world. “I ...
... population of middle-aged cystic fibrosis patients contains significantly more ... lived for decades without a diagnosis or specialized care, ... Health. The comprehensive analysis of this over-40 cohort, published ... Respiratory and Critical Care , may help guide future ...
... are still being prescribed for extended periods to British Columbian ... warnings against long-term use, according to a University of British ... Policy , the study by researchers at UBC,s Centre for ... its kind to examine the use of benzodiazepines such as ...
... , WEDNESDAY, May 19 (HealthDay News) -- Two common ... equally effective, a new study reveals, but each option ... slings, the techniques are often used to address stress ... as coughing, sneezing or laughing. , Urinary incontinence affects ...
Cached Medicine News:Health News:Celebrate Mental Health Month with Your Child; Make Sure a Valuing Relationship is in Place 2Health News:FemFlora Reformulated with New Complex of Probiotic Bacteria 2Health News:New Laser Technology Combined with Manual Physical Therapy Offer Pain Relief to Chronic Pain Sufferers 2Health News:Older patients offer insight into the future of cystic fibrosis 2Health News:Older patients offer insight into the future of cystic fibrosis 3Health News:Long-term use of anti-anxiety drugs continues in B.C. despite known health risks: UBC study 2Health News:Female Incontinence Surgeries Look Equally Effective 2
... fume containment system is ... equipment. Even large benchtop ... the Hyperclean 2. The ... unit comes complete with one ...
Reusable shielded cable...
... OIA test features a dual-detection technology to ... for children under age 5 with a ... in just over 15 minutes. This combination ... to decrease costs for unnecessary ancillary testing, ...
... OIA A/B test combines performance equivalence to 14-day ... A or B with a simple, easy-to-use test ... test has all the same procedural steps as ... enable you decrease costs for unnecessary ancillary testing, ...
Medicine Products: